Anastrozole

CAS 120511-73-1 25 API suppliersSmall Molecule

Overview

Anastrozole is a non-steroidal aromatase inhibitor used primarily to treat estrogen receptor-positive breast cancer by reducing estrogen levels in the body. It is particularly effective in postmenopausal women.

API suppliers (26)

Suppliers of Anastrozole evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India10China4Taiwan2Netherlands1Canada1Germany1USA1Israel1

Country recorded for 21 of 26 suppliers.

14 of 26 hold a GMP certificate on record in the EU or UK registers · 1 holds a European CEP for this substance

Showing 25 of 26 suppliers — see the full list in the app.

Chemical identity

IUPAC name
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
Canonical SMILES
CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
InChIKey
YBBLVLTVTVSKRW-UHFFFAOYSA-N

Therapeutic areas

OncologyEndocrinology
Verified Supplier Partner

Do you supply Anastrozole? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.